UPDATE: Hanson Wade have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause. Register your interest here if you would like updates on the meeting or topic

The inaugural Biomolecular Condensates Summit is uniting biopharma and academia to address the knowledge gap in understanding the role of biomolecular condensates in disease biology and progression and to advance biomolecular condensates as viable therapeutic targets.

Taking things back to the drawing board, this meeting will seek to re-think the current understanding of condensate defining criteria, explore specific functions of condensates in diseases state and evaluate what role they may play in both neurodegenerative diseases and cancer.

This meeting is built for; medicinal chemistry, molecular biology, pathology and drug discovery functions to tackle the challenges and therapeutically target biomolecular condensates. Sign up today and join the one of the major discovery efforts at the frontier of science.